| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
| | FI | | I/B | Atgam 250 mg/5 ml | 5 x 5 ml | PA | PA | k.A. | | Infusionskonzentrat: Immunoglobulinum Anti-T Limphocytorum ex Equus 50 mg | Pfizer AG | A | FB | | G |  |
|
L | | FI | | I/B | GRAFALON | Durchstechflasche(n) | 372.42 | 421.45 | 10% | | Infusionskonzentrat: Immunoglobulinum Anti-T Limphocytorum ex Cuniculus 20 mg/ml | Neovii Pharmaceuticals AG | B / SL | FB | | G |  |
L | | FI | | I/B | GRAFALON | 10 Durchstechflasche(n) | 3718.42 | 4060.40 | 10% | | Infusionskonzentrat: Immunoglobulinum Anti-T Limphocytorum ex Cuniculus 20 mg/ml | Neovii Pharmaceuticals AG | B / SL | FB | | G |  |
| | FI | | I/B | Thymoglobuline | Durchstechflasche(n) | PA | PA | k.A. | | poudre pour solution à diluer pour perfusion: Immunoglobulinum Anti-T Limphocytorum ex Cuniculus 25 mg | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | FI | | | Atgam | 5 x 5 ml | PA | 2005.60 | k.A. | | Injektionslösung: Immunoglobulinum Antithymocyticum Equi 250 mg | Pharmacia AG | B | FB | | G |  |
|
| | FI | | | Cellcept 500 mg | 150 | 224.86 | 259.70 | 10% | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Cellcept 250 mg | 300 | 245.59 | 282.15 | 10% | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B / SL / SO | FB | | G |  |
| | FI | | | Cellcept 500 mg | 150 | PA | PA | k.A. | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 500 mg | 150 | PA | PA | k.A. | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 500 mg | 150 | PA | PA | k.A. | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 250 mg | 300 | PA | PA | k.A. | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 250 mg | 300 | PA | PA | k.A. | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 250 mg | 300 | PA | PA | k.A. | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | PI | | Cellcept 500 mg - T | 50 Tablette(n) | 90.85 | 115.20 | 40% | | Filmtabletten: Mofetili Mycophenolas 500 mg | Roche Pharma (Schweiz) AG | B / SL / SO | FB | | G |  |
| | FI | | | Cellcept 500 mg | 50 | 74.96 | 97.95 | 10% | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Cellcept 500 mg - T | 150 | 272.56 | 308.65 | 40% | | Filmtabletten: Mofetili Mycophenolas 500 mg | Roche Pharma (Schweiz) AG | B / SL / SO | FB | | G |  |
| | FI | | | Cellcept 500 mg | 150 | 224.86 | 259.70 | 10% | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Cellcept 250 mg | 100 Kapsel(n) | 99.23 | 124.35 | 40% | | Kapseln: Mofetili Mycophenolas 250 mg | Roche Pharma (Schweiz) AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Cellcept 250 mg | 100 | 81.88 | 105.45 | 10% | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Cellcept 250 mg | 300 | 297.69 | 335.60 | 40% | | Kapseln: Mofetili Mycophenolas 250 mg | Roche Pharma (Schweiz) AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Cellcept 250 mg | 300 | 245.59 | 282.15 | 10% | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Mycophenolat-Mofetil Sandoz 500 mg | 150 Tablette(n) | 204.42 | 238.75 | 10% | | Filmtabletten: Mofetili Mycophenolas 500 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Myfenax 500 mg | 3 x 50 | 204.42 | 238.75 | 10% | | Filmtabletten: Mofetili Mycophenolas 500 mg | Teva Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Mycophenolat-Mofetil Sandoz | 300 Kapsel(n) | 223.27 | 259.25 | 10% | | Kapseln: Mofetili Mycophenolas 250 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Myfenax 250 mg | 3 x 100 | 223.28 | 259.25 | 10% | | Kapseln: Mofetili Mycophenolas 250 mg | Teva Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Cellcept | Flasche(n) à 35 g | 148.18 | 177.55 | 10% | | Pulver zur Herstellung einer Suspension zum Einnehmen: Mofetili Mycophenolas 200 mg | Roche Pharma (Schweiz) AG | B / SL | FB | | G |  |
| | FI | PI | | Myfortic 180 mg | 120 Tablette(n) | 125.48 | 152.90 | 10% | | magensaftresistente Filmtabletten: Acidum Mycophenolicum 180 mg | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | | Myfortic 360 mg | 120 Tablette(n) | 229.66 | 266.20 | 10% | | magensaftresistente Filmtabletten: Acidum Mycophenolicum 360 mg | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | | Cellcept i.v. | 4 Durchstechflasche(n) | PA | 184.30 | k.A. | | Lyophilisat: Mofetili Mycophenolas 500 mg | Roche Pharma (Schweiz) AG | B | FB | | G |  |
| | FI | | | Cellcept 500 mg | 50 | PA | PA | k.A. | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 500 mg | 50 | PA | PA | k.A. | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 500 mg | 50 | PA | PA | k.A. | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | PI | | Cellcept 500 mg - T | 150 | 371.07 | 442.40 | k.A. | | Filmtabletten: Mofetili Mycophenolas 500 mg | Roche Pharma (Schweiz) AG | B | FB | | G |  |
| | FI | | | Cellcept 500 mg | 150 | PA | PA | k.A. | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 500 mg | 150 | PA | PA | k.A. | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 500 mg | 150 | PA | PA | k.A. | | Filmtabletten: Mofetili Mycophenolas 500 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 250 mg | 100 | PA | PA | k.A. | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 250 mg | 100 | PA | PA | k.A. | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 250 mg | 100 | PA | PA | k.A. | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | PI | | Cellcept 250 mg | 300 | 405.28 | 481.65 | k.A. | | Kapseln: Mofetili Mycophenolas 250 mg | Roche Pharma (Schweiz) AG | B | FB | | G |  |
| | FI | | | Cellcept 250 mg | 300 | PA | PA | k.A. | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 250 mg | 300 | PA | PA | k.A. | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | | | Cellcept 250 mg | 300 | PA | PA | k.A. | | Kapseln: Mofetili Mycophenolas 250 mg | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
|
| | FI | PI | | Arava 10 mg ‐ F | 30 Tablette(n) | 11.81 | 29.20 | 10% | | Filmtabletten: Leflunomidum 10 mg | Sanofi-Aventis (Suisse) SA | A / SL / SO | FB | | G |  |
| | FI | PI | | Arava 10 mg ‐ F | 100 Tablette(n) | 39.37 | 59.05 | 10% | | Filmtabletten: Leflunomidum 10 mg | Sanofi-Aventis (Suisse) SA | A / SL / SO | FB | | G |  |
| | FI | PI | | Arava 20 mg | 30 Tablette(n) | 20.71 | 38.85 | 10% | | Filmtabletten: Leflunomidum 20 mg | Sanofi-Aventis (Suisse) SA | A / SL / SO | FB | | G |  |
| | FI | PI | | Arava 20 mg | 100 Tablette(n) | 69.04 | 91.20 | 10% | | Filmtabletten: Leflunomidum 20 mg | Sanofi-Aventis (Suisse) SA | A / SL / SO | FB | | G |  |
| | FI | PI | | Arava 100 mg | 3 Tablette(n) | 12.55 | 29.95 | 10% | | Filmtabletten: Leflunomidum 100 mg | Sanofi-Aventis (Suisse) SA | A / SL / SO | FB | | G |  |
| | FI | PI | | Leflunomid Gebro 10 mg | 3 x 10 | 10.74 | 28.10 | 10% | | Filmtabletten: Leflunomidum 10 mg | Gebro Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Gebro 10 mg | 10 x 10 | 35.80 | 55.40 | 10% | | Filmtabletten: Leflunomidum 10 mg | Gebro Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Gebro 20 mg | 3 x 10 | 18.83 | 36.90 | 10% | | Filmtabletten: Leflunomidum 20 mg | Gebro Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Gebro 20 mg | 10 x 10 | 62.77 | 84.75 | 10% | | Filmtabletten: Leflunomidum 20 mg | Gebro Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Sandoz 10 | 30 Tablette(n) | 10.74 | 28.10 | 10% | | Filmtabletten: Leflunomidum 10 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Sandoz 10 | 100 Tablette(n) | 35.80 | 55.40 | 10% | | Filmtabletten: Leflunomidum 10 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Sandoz 20 | 30 Tablette(n) | 18.83 | 36.90 | 10% | | Filmtabletten: Leflunomidum 20 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Sandoz 20 | 100 Tablette(n) | 62.77 | 84.75 | 10% | | Filmtabletten: Leflunomidum 20 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Spirig HC 10 mg | 30 Tablette(n) | 11.30 | 28.70 | 10% | | Filmtabletten: Leflunomidum 10 mg | Spirig HealthCare AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Spirig HC 10 mg | 100 Tablette(n) | 37.41 | 57.05 | 10% | | Filmtabletten: Leflunomidum 10 mg | Spirig HealthCare AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Spirig HC 20 mg | 30 Tablette(n) | 19.81 | 37.90 | 10% | | Filmtabletten: Leflunomidum 20 mg | Spirig HealthCare AG | ● A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Spirig HC 20 mg | 100 Tablette(n) | 66.03 | 88.10 | 10% | | Filmtabletten: Leflunomidum 20 mg | Spirig HealthCare AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Spirig HC 100 mg | 3 Tablette(n) | 11.30 | 28.70 | 10% | | Filmtabletten: Leflunomidum 100 mg | Spirig HealthCare AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid-Mepha 10 | 30 Tablette(n) | 11.30 | 28.70 | 10% | | Filmtabletten: Leflunomidum 10 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid-Mepha 10 | 100 Tablette(n) | 37.42 | 57.05 | 10% | | Filmtabletten: Leflunomidum 10 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid-Mepha 20 | 30 Tablette(n) | 19.81 | 37.90 | 10% | | Filmtabletten: Leflunomidum 20 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid-Mepha 20 | 100 Tablette(n) | 66.03 | 88.10 | 10% | | Filmtabletten: Leflunomidum 20 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | CM | Leflunomide Zentiva 10 mg | 30 Tablette(n) | 10.75 | 28.10 | 10% | | Filmtabletten: Leflunomidum 10 mg | Helvepharm AG | A / SL / SG | FB | | G |  |
| | FI | PI | CM | Leflunomide Zentiva 10 mg | 100 Tablette(n) | 35.83 | 55.40 | 10% | | Filmtabletten: Leflunomidum 10 mg | Helvepharm AG | A / SL / SG | FB | | G |  |
| | FI | PI | CM | Leflunomide Zentiva 20 mg | 30 Tablette(n) | 18.83 | 36.90 | 10% | | Filmtabletten: Leflunomidum 20 mg | Helvepharm AG | A / SL / SG | FB | | G |  |
| | FI | PI | CM | Leflunomide Zentiva 20 mg | 100 Tablette(n) | 62.77 | 84.75 | 10% | | Filmtabletten: Leflunomidum 20 mg | Helvepharm AG | A / SL / SG | FB | | G |  |
| | FI | PI | CM | Leflunomide Zentiva 100 mg | 3 Tablette(n) | 10.75 | 28.10 | 10% | | Filmtabletten: Leflunomidum 100 mg | Helvepharm AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Leflunomid Gebro 10 mg | 30 Tablette(n) | 16.04 | 34.80 | k.A. | | Filmtabletten: Leflunomidum 10 mg | Gebro Pharma AG | A | FB | | G |  |
| | FI | PI | | Leflunomid Gebro 10 mg | 100 Tablette(n) | 53.89 | 78.25 | k.A. | | Filmtabletten: Leflunomidum 10 mg | Gebro Pharma AG | A | FB | | G |  |
| | FI | PI | | Leflunomid Gebro 20 mg | 30 Tablette(n) | 28.13 | 48.70 | k.A. | | Filmtabletten: Leflunomidum 20 mg | Gebro Pharma AG | A | FB | | G |  |
| | FI | PI | | Leflunomid Gebro 20 mg | 100 Tablette(n) | 98.64 | 129.65 | k.A. | | Filmtabletten: Leflunomidum 20 mg | Gebro Pharma AG | A | FB | | G |  |
| | FI | PI | | Leflunomid Gebro 100 mg | 3 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Leflunomidum 100 mg | Gebro Pharma AG | A | FB | | G |  |
| | FI | PI | | Leflunomid-Mepha 100 | 3 Tablette(n) | 36.78 | 58.60 | k.A. | | Filmtabletten: Leflunomidum 100 mg | Mepha Pharma AG | A | FB | | G |  |
|
| | FI | PI | | Certican 0.1 mg | 60 Tablette(n) | 58.26 | 79.80 | 10% | | Dispersible Tabletten: Everolimusum | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | | Certican 0.25 mg | 60 Tablette(n) | 145.64 | 174.80 | 10% | | Tabletten: Everolimusum | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | | Certican 0.5 mg | 60 Tablette(n) | 291.27 | 333.20 | 10% | | Tabletten: Everolimusum | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | | Certican 0.75 mg | 60 Tablette(n) | 436.91 | 491.60 | 10% | | Tabletten: Everolimusum | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | | Certican 1 mg | 60 Tablette(n) | 582.55 | 649.95 | 10% | | Tabletten: Everolimusum 1 mg | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
|
L | | FI | PI | | Orencia 125 mg/1 ml | 4 | 945.54 | 1044.75 | 10% | | Injektionslösung zur subkutanen Anwendung (Fertigpen): Abataceptum 125 mg/ml | Bristol-Myers Squibb SA | B / SL | FB | | G |  |
L | | FI | PI | | Orencia | 4 Fertigspritze(n) | 945.54 | 1044.75 | 10% | | Injektionslösung zur subkutanen Anwendung (Fertigspritze mit Nadelschutz): Abataceptum 125 mg/ml | Bristol-Myers Squibb SA | B / SL | FB | | G |  |
L | KFI | FI | | | Orencia 250 mg | Durchstechflasche(n) | 344.08 | 390.60 | 10% | | Pulver zur Herstellung eines Infusionslösungkonzentrats: Abataceptum 250 mg | Bristol-Myers Squibb SA | A / SL | FB | | G |  |
|
L | | FI | | | Fingolimod Devatis 0.5 mg | 28 | 380.52 | 430.25 | 10% | | Kapseln: Fingolimodum | Devatis AG | B / SL / SG | FB | | G |  |
L | | FI | | | Fingolimod Devatis 0.5 mg | 98 | 1331.83 | 1464.85 | 10% | | Kapseln: Fingolimodum | Devatis AG | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Fingolimod Sandoz 0.5 mg | 28 | 380.52 | 430.25 | 10% | | Kapseln: Fingolimodum | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Fingolimod Sandoz 0.5 mg | 98 | 1331.83 | 1464.85 | 10% | | Kapseln: Fingolimodum | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Fingolimod Viatris 0,5 mg | 28 | 380.52 | 430.25 | 10% | | Kapseln: Fingolimodum | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | FI | PI | | Fingolimod Viatris 0,5 mg | 98 | 1331.83 | 1464.85 | 10% | | Kapseln: Fingolimodum | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | FI | | | Fingolimod-Mepha 0,5 mg | 28 | 380.52 | 430.25 | 10% | | Kapseln: Fingolimodum | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | | | Fingolimod-Mepha 0,5 mg | 98 | 1331.83 | 1464.85 | 10% | | Kapseln: Fingolimodum | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Fingolimod Devatis 0.25 mg | 7 | PA | PA | k.A. | | Kapseln: Fingolimodum | Devatis AG | B | FB | | G |  |
| | FI | PI | | Fingolimod Devatis 0.25 mg | 28 | PA | PA | k.A. | | Kapseln: Fingolimodum | Devatis AG | B | FB | | G |  |
| | FI | | | Fingolimod Devatis 0.5 mg | 7 | PA | PA | k.A. | | Kapseln: Fingolimodum | Devatis AG | B | FB | | G |  |
| | FI | | | Fingolimod Devatis 0.5 mg | 84 | PA | PA | k.A. | | Kapseln: Fingolimodum | Devatis AG | B | FB | | G |  |
| | FI | | CM | Fingolimod Sandoz 0.25 mg | 7 | PA | PA | k.A. | | Kapseln: Fingolimodum | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | FI | | CM | Fingolimod Sandoz 0.25 mg | 28 | PA | PA | k.A. | | Kapseln: Fingolimodum | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | FI | PI | | Fingolimod-Mepha 0,25 mg | 7 | PA | PA | k.A. | | Kapseln: Fingolimodum | Mepha Pharma AG | B | FB | | G |  |
| | FI | PI | | Fingolimod-Mepha 0,25 mg | 28 | PA | PA | k.A. | | Kapseln: Fingolimodum | Mepha Pharma AG | B | FB | | G |  |
| | FI | PI | | Fingolimod-Mepha 0,25 mg | 84 | PA | PA | k.A. | | Kapseln: Fingolimodum | Mepha Pharma AG | B | FB | | G |  |
| | FI | PI | | Fingolimod-Mepha 0,25 mg | 98 | PA | PA | k.A. | | Kapseln: Fingolimodum | Mepha Pharma AG | B | FB | | G |  |
| | FI | | | Fingolimod-Mepha 0,5 mg | 84 | PA | PA | k.A. | | Kapseln: Fingolimodum | Mepha Pharma AG | B | FB | | G |  |
|
L | | FI | | PS | Nulojix 250 mg | | 391.50 | 442.20 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Belataceptum 250 mg | Bristol-Myers Squibb SA | A / SL | FB | | G |  |
L | | FI | | PS | Nulojix 250 mg | 2 | 783.00 | 868.00 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Belataceptum 250 mg | Bristol-Myers Squibb SA | A / SL | FB | | G |  |
|
L | | FI | PI | | Otezla 30mg | 56 Tablette(n) | 601.03 | 670.05 | 10% | | Filmtabletten: Apremilastum 30 mg | Amgen Switzerland AG | B / SL | FB | | G |  |
L | | FI | PI | | Otezla 10 mg, 20 mg | 19 Tablette(n) | 284.43 | 325.75 | 10% | | mg: Apremilastum 10 mg mg: Apremilastum 20 mg mg: Apremilastum 30 mg | Amgen Switzerland AG | B / SL | FB | | G |  |
|
L | | FI | PI | | Lemtrada 10 mg/ml | Durchstechflasche(n) | 6740.57 | 7223.60 | 10% | | Infusionskonzentrat: Alemtuzumabum 12mg / 1.2ml | Sanofi-Aventis (Suisse) SA | A / SL | FB | | G |  |
|
L | | FI | PI | PS | Olumiant 2 mg | 28 | 871.24 | 963.95 | 10% | | Filmtabletten: Baricitinibum 2 mg | Eli Lilly (Suisse) SA | B / SL | FB | | G |  |
L | | FI | PI | PS | Olumiant 4 mg | 28 | 871.24 | 963.95 | 10% | | Filmtabletten: Baricitinibum 4 mg | Eli Lilly (Suisse) SA | B / SL | FB | | G |  |
|
L | | FI | PI | | Mavenclad 10 mg | | 2348.19 | 2570.20 | 10% | | Tabletten: Cladribinum 10 mg | Merck (Schweiz) AG | A / SL | FB | | G |  |
L | | FI | PI | | Mavenclad 10 mg | 4 | 9392.76 | 9944.75 | 10% | | Tabletten: Cladribinum 10 mg | Merck (Schweiz) AG | A / SL | FB | | G |  |
L | | FI | PI | | Mavenclad 10 mg | 6 | 14089.14 | 14763.25 | 10% | | Tabletten: Cladribinum 10 mg | Merck (Schweiz) AG | A / SL | FB | | G |  |
|
| | FI | | | Uplizna 100 mg/10ml | 3 | PA | PA | k.A. | | Infusionskonzentrat: Inebilizumabum 100mg / 10ml | Amgen Switzerland AG | A | FB | | G |  |